title: Support for the RV144 HIV vaccine trial.
authors.forename: Robert
authors.initials: R
authors.lastname: Belshe
authors.forename: Genoveffa
authors.initials: G
authors.lastname: Franchini
authors.forename: Marc P
authors.initials: MP
authors.lastname: Girard
authors.forename: Frances
authors.initials: F
authors.lastname: Gotch
authors.forename: Pontiano
authors.initials: P
authors.lastname: Kaleebu
authors.forename: Marta L
authors.initials: ML
authors.lastname: Marthas
authors.forename: Michael B
authors.initials: MB
authors.lastname: McChesney
authors.forename: Rose
authors.initials: R
authors.lastname: McCullough
authors.forename: Fred
authors.initials: F
authors.lastname: Mhalu
authors.forename: Dominique
authors.initials: D
authors.lastname: Salmon-Ceron
authors.forename: Rafick-Pierre
authors.initials: RP
authors.lastname: Sekaly
authors.forename: Koen
authors.initials: K
authors.lastname: van Rompay
authors.forename: Bernard
authors.initials: B
authors.lastname: Verrier
authors.forename: Britta
authors.initials: B
authors.lastname: Wahren
authors.forename: Mercedes
authors.initials: M
authors.lastname: Weissenbacher
mesh_terms: D016915:AIDS Vaccines / Q000008:administration & dosage / Q000276:immunology; D017326:Clinical Trials, Phase III as Topic; D015483:HIV Antibodies / Q000276:immunology; D015658:HIV Infections / Q000276:immunology* / Q000517:prevention & control / Q000628:therapy; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular; D007115:Immunization Schedule; D007117:Immunization, Secondary; D013785:Thailand; D014481:United States
chemical_list: D016915:AIDS Vaccines; D015483:HIV Antibodies